Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dianthus Therapeutics (DNTH) Shares Outstanding (Diluted Average): 2022-2024

Historic Shares Outstanding (Diluted Average) for Dianthus Therapeutics (DNTH) over the last 3 years, with Dec 2024 value amounting to $33.3 million.

  • Dianthus Therapeutics' Shares Outstanding (Diluted Average) rose 10.39% to $37.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.8 million, marking a year-over-year increase of 10.39%. This contributed to the annual value of $33.3 million for FY2024, which is 546.44% up from last year.
  • Latest data reveals that Dianthus Therapeutics reported Shares Outstanding (Diluted Average) of $33.3 million as of FY2024, which was up 546.44% from $5.2 million recorded in FY2023.
  • Dianthus Therapeutics' 5-year Shares Outstanding (Diluted Average) high stood at $33.3 million for FY2024, and its period low was $874,234 during FY2022.
  • Over the past 3 years, Dianthus Therapeutics' median Shares Outstanding (Diluted Average) value was $5.2 million (recorded in 2023), while the average stood at $13.1 million.
  • Data for Dianthus Therapeutics' Shares Outstanding (Diluted Average) shows a peak YoY soared of 546.44% (in 2024) over the last 5 years.
  • Over the past 3 years, Dianthus Therapeutics' Shares Outstanding (Diluted Average) (Yearly) stood at $874,234 in 2022, then soared by 489.48% to $5.2 million in 2023, then soared by 546.44% to $33.3 million in 2024.